About Reneo Pharmaceuticals

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
275,Irvine,California,US
Description
Information
Reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. Many of these diseases are associated with deficits in cellular metabolism and energy production. Our goal is to improve daily function and quality of life of patients suffering from these diseases, most specifically, by improving how their mitochondria work, preserving muscle function and preventing muscle injury, weakness and wasting. We are currently advancing a novel molecule into several diseases. Our experienced team of drug development experts, who have collaborated in many successful programs, are dedicated and passionate about finding effective therapies for these complex rare diseases.

Reneo Pharmaceuticals Alternatives

Industry
biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about Reneo Pharmaceuticals

What is Reneo Pharmaceuticals email format?

The widely used Reneo Pharmaceuticals email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Reneo Pharmaceuticals customer service number?

To contact Reneo Pharmaceuticals customer service number call here 1 858.283.0280. To contact Reneo Pharmaceuticals customer service number in your country click here to find.


Who is the CEO of Reneo Pharmaceuticals?

Gregory J Flesher is the CEO of Reneo Pharmaceuticals.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more